Volitionrx Other Stockholder Equity from 2010 to 2025

VNRX Stock  USD 0.62  0.02  3.13%   
Volitionrx Other Stockholder Equity yearly trend continues to be fairly stable with very little volatility. Other Stockholder Equity is likely to outpace its year average in 2025. During the period from 2010 to 2025, Volitionrx Other Stockholder Equity regression line of annual values had r-squared of  0.96 and arithmetic mean of  93,514,052. View All Fundamentals
 
Other Stockholder Equity  
First Reported
2004-09-30
Previous Quarter
195.8 M
Current Value
202 M
Quarterly Volatility
67.1 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Volitionrx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Volitionrx's main balance sheet or income statement drivers, such as Interest Expense of 267.6 K, Other Operating Expenses of 44.4 M or Total Operating Expenses of 44.4 M, as well as many indicators such as Price To Sales Ratio of 71.97, Dividend Yield of 0.0 or Days Sales Outstanding of 122. Volitionrx financial statements analysis is a perfect complement when working with Volitionrx Valuation or Volatility modules.
  
Check out the analysis of Volitionrx Correlation against competitors.
For more information on how to buy Volitionrx Stock please use our How to Invest in Volitionrx guide.

Latest Volitionrx's Other Stockholder Equity Growth Pattern

Below is the plot of the Other Stockholder Equity of Volitionrx over the last few years. It is Volitionrx's Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Volitionrx's overall financial position and show how it may be relating to other accounts over time.
Other Stockholder Equity10 Years Trend
Slightly volatile
   Other Stockholder Equity   
       Timeline  

Volitionrx Other Stockholder Equity Regression Statistics

Arithmetic Mean93,514,052
Geometric Mean36,634,216
Coefficient Of Variation86.52
Mean Deviation68,471,307
Median85,604,271
Standard Deviation80,908,701
Sample Variance6546.2T
Range234.8M
R-Value0.98
Mean Square Error270.3T
R-Squared0.96
Slope16,663,529
Total Sum of Squares98193.3T

Volitionrx Other Stockholder Equity History

2025234.8 M
2024223.6 M
2023194.4 M
2022164.4 M
2021154.7 M
2020126.5 M
2019103.9 M

About Volitionrx Financial Statements

Volitionrx investors use historical fundamental indicators, such as Volitionrx's Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Volitionrx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Stockholder Equity223.6 M234.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Volitionrx Stock Analysis

When running Volitionrx's price analysis, check to measure Volitionrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Volitionrx is operating at the current time. Most of Volitionrx's value examination focuses on studying past and present price action to predict the probability of Volitionrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Volitionrx's price. Additionally, you may evaluate how the addition of Volitionrx to your portfolios can decrease your overall portfolio volatility.